Delay discounting, locus of control, and cognitive impulsiveness independently predict tobacco dependence treatment outcomes in a highly dependent, lower socioeconomic group of smokers
- PMID: 22494224
- PMCID: PMC3567840
- DOI: 10.1111/j.1521-0391.2012.00224.x
Delay discounting, locus of control, and cognitive impulsiveness independently predict tobacco dependence treatment outcomes in a highly dependent, lower socioeconomic group of smokers
Abstract
Tobacco use disproportionately affects lower socioeconomic status (SES) groups. Current explanations as to why lower SES groups respond less robustly to tobacco control efforts and tobacco dependence treatment do not fully account for this disparity. The identification of factors that predict relapse in this population might help to clarify these differences. Good candidates for novel prognostic factors include the constellation of behaviors associated with executive function including self-control/impulsiveness, the propensity to delay reward, and consideration and planning of future events. This study examined the ability of several measures of executive function and other key clinical, psychological, and cognitive factors to predict abstinence for highly dependent lower SES participants enrolled in intensive cognitive-behavioral treatment for tobacco dependence. Consistent with predictions, increased discounting and impulsiveness, an external locus of control as well as greater levels of nicotine dependence, stress, and smoking for negative affect reduction predicted relapse. These findings suggest that these novel factors are clinically relevant in predicting treatment outcomes and suggest new targets for therapeutic assessment and treatment approaches.
Copyright © American Academy of Addiction Psychiatry.
Conflict of interest statement
Declaration of Interest
Dr. Bickel is a principal in HealthSIm LLC. Drs. MacKillop, McGreary, Landes, Stitzer, Yi, Jones, and Christensen and Ms. Jackson report no competing financial interests or potential conflicts of interest. Dr. Carter is now employed by Jazz Pharmaceuticals, PLC and has a financial interest in Jazz Pharmaceuticals, PLC. The authors alone are responsible for the content and writing of this paper.
References
-
- Mokdad AH, Marks JS, Stroup DF, et al. Actual causes of death in the United States 2000. JAMA. 2004;291:1238–1245. - PubMed
-
- CDC. Annual smoking-attributable mortality, years of potential life lost, and economic costs: United States, 1997–2001. Morb Mortal Wkly Rep. 2005;54:625–628. - PubMed
-
- Centers for Disease Control and Prevention. Behavioral risk factor surveillance system survey data. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2010. Retrieved from http://apps.nccd.cdc.gov/brfss/CDC.
-
- Fiore MC, Novotny TE, Pierce JP, et al. Trends in cigarette smoking in the United States. The changing influence of gender and race. JAMA. 1989;261:49–55. - PubMed
-
- Treating tobacco use and dependence: 2008 update. Rockville, MD: U.S. Department of Health and Human Services Public Health Service; 2008.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
